Introduction {#s1}
============

The Porcine Reproductive and Respiratory Syndrome virus (PRRSV) is responsible for huge economic losses in pig industry. PRRSV belongs to the *Nidovirales* order, the *Arteriviradae* family, and the *Porartevirus* genus (ICTV 2017 Release). Two different species, PRRSV-1 and PRRSV-2 are now distinguished ([@B1]). PRRSV-1 have further been divided into 4 subtypes. PRRSV-1 subtype 1 (PRRSV-1.1) is present in all part of Europe, while PRRSV-1.2, 1.3, and 1.4 are mostly present in Eastern Europe ([@B2]). PRRSV-1.3 such as Lena, are more pathogenic than PRRSV-1.1 as Lelystad virus (LV) ([@B3]--[@B6]). The infection by PRRSV-1.3 is characterized by higher body temperature, more sever clinical signs and lung pathology compared to PRRSV-1.1, whereas viremia and lung viral load are not consistently higher ([@B5], [@B7]).

A lag of several weeks in the clearance of the PRRSV has been observed, mostly attributed to a delay in neutralizing antibodies appearance, although an inhibition of the cellular IFNγ response, less studied, might also be involved \[for review see ([@B8], [@B9])\]. It has been reported that virulent PRRSV-1.3 induced a strong early inflammatory response associated with an enhanced adaptive cellular immune response that may participate to their higher pathogenicity ([@B5]).

The main cellular targets of PRRSV are macrophages ([@B10]). Extracellular sialoadhesin (CD169/Siglec-1) mediates viral internalization via interaction with viral protein GP5/M heterodimer while CD163 receptor plays a role in viral internalization and disassembly interacting with GP2 and GP4 viral proteins ([@B11]). In addition to macrophages, other immune cells have been described to be permissive to PRRSV *in vitro*. Cultured blood monocytes, monocyte-derived dendritic cells (moDCs) ([@B12]) and bone marrow-derived dendritic cells (bmDC) ([@B13]) are susceptible to infection by a large range of PRRSV-1 strains. Nevertheless, *in vitro* differentiation conditions might strongly impact the susceptibility of DC/macrophages to PRRSV ([@B14]). In 2013, Frydas et al. showed that virulent PRRSV-1.3 such as Lena were able, *ex vivo*, to infect a broader range of monocytic lineage subpopulations than LV PRRSV-1.1 ([@B15]).

Dendritic cells (DCs) and macrophages are mononuclear phagocyte cells (MPC) belonging to the mononuclear phagocyte system ([@B16]). DCs are key inducers of adaptive immune responses, they migrate from infected tissues to lymph nodes in order to present antigens and induce the humoral and cellular adaptive immune responses. One running hypothesis is that the differences in pathogenicity of the PRRSV strains might be due to their differential abilities to infect or activate DCs, impacting the inflammatory response as well as the mounting of a protective adaptive immune response. Two studies tentatively tackled the lung DCs infection *in vivo* by PRRSV-1 and 2 respectively ([@B17], [@B18]). However, none of them clearly defined nor distinguished DCs and macrophages, leading to results that cannot be clearly interpreted in terms of DCs/PRRSV interactions. We recently identified porcine respiratory DC and macrophage subpopulations and classified them according to a nomenclature proposed by Guilliams et al. ([@B19], [@B20]). In accordance with knowledge in human and mice, we observed that porcine respiratory DCs presented migratory and naïve T-cell stimulation capacities. Conventional DC1 preferentially inducing a T-helper (Th) 1 response, cDC2 a Th2 response and monocyte-derived DC (moDC) a Th17 response. Moreover moDC produced inflammatory cytokines such as IL1 and IL8, and their proportion increased upon viral infection ([@B21]). These populations represent *in vivo* differentiated respiratory DCs and macrophages which can be investigated for their interactions with PRRSV in their natural *in vivo* environment.

In order to explore the role of PRRSV/DCs interactions in the induction of the immune response, we studied the infection of primary lung DCs *in vivo* and *in vitro* as well as the impact of PRRSV infection on DCs functionalities. Highly virulent Lena PRRSV-1.3 was tested *in vivo* and compared *in vitro* with two PRRSV-1.1, namely LV and the newly emerging pathogenic Flanders13 (FL13) ([@B15]). We found that primary lung DCs were not infected by any of these strains and that a strong cDC1/Type 1 immune response was activated by Lena, but not by FL13 and LV.

Materials and methods {#s2}
=====================

Virus production and titration
------------------------------

The 3 strains of PRRSV used in this study were kindly provided by Dr. Hans Nauwynck, (University of Ghent, Belgium). The highly pathogenic Lena PRRSV-1.3 was used for *in vivo* and *in vitro* infections. Lena has been isolated in Belarus in 2007 from a herd with mortality, reproductive failures and respiratory disorders ([@B22]). Lelystad virus was identified in the Netherlands in 1991 ([@B23]) and Flanders13 13V091 was isolated in Belgium in 2013 in farms experiencing uncommon long-lasting anorexia, fever and respiratory problems within the first 2 weeks after weaning during enzootic PRRSV infection.

Lena viral stock for *in vivo* experiment was produced using SPF piglets AM. The production was tested negative for PCV2, swine Influenza, *Mycoplasma hyopneumoniae*, classical swine fevers as well as African swine fever. A bacteria culture was also negative. For *in vitro* experiments, Lena, Fl13 and LV stocks were produced using fresh SPF primary alveolar macrophages. Supernatants from infected cells were clarified by centrifugation at 3,300 G, filtered on 0.8 μm. Then 30 ml of supernatant were layered on 4 ml 17% sucrose cushion and centrifuged at 100,000 G for 5 h30 min. The pelleted virus was resuspended in RPMI. Titration of viruses were performed on fresh primary alveolar macrophages using Spearman-Karber TCID50 method according to the OIE manual of diagnostic tests (OIE, "Chapter 2.8.7 Porcine Reproductive and Respiratory Syndrome," Terr. Man., no. May 2015, 2015).

*In vivo* infection and tissue collection
-----------------------------------------

For *in vivo* experiment, PRRSV infection was performed at ANSES (Ploufragan, France). The animal experiment was authorized by the French Ministry for Research (authorization no. 2015060113297443) and protocols were approved by the national ethics committee (authorization no. 07/07/15-3). Eight Large White piglets coming from a nucleus herd (free from PRRSV, *Actinobacillus pleuropneumoniae, M. hyopneumoniae)* used as control in another publication ([@B24]), were housed in biosecurity level-3 air-filtered animal facilities. Treatments, housing, and husbandry conditions were conformed to the European Union Guidelines (Directive 2010/63/EU on the protection of animals used for scientific purposes). At 10 weeks of age, 4 pigs were inoculated intranasally with Lena (5.10^5^ TCID50/per animal in 2.5 ml per nostril). Ten days post-infection, animals were anesthetized (Zoletil, Virbac, France) and exsanguinated. Broncho-alveolar lavage (BAL) cells were collected using 500 ml of PBS + 2 mM EDTA (PBS/EDTA) for each lung. After BAL procedure, peripheral parenchymal tissue from diaphragmatic lobes (PAR) were sampled, minced and incubated in complete RPMI consisting of RPMI 1640 medium supplemented with 100 IU/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine and 10% inactivated fetal calf serum (FCS) (Invitrogen, Paisley, UK). Tissue digestion was performed by adding 2 mg/ml collagenase D (Roche, Meylan, France), 1 mg/ml dispase (Invitrogen) and 0.1 mg/ml Dnase I (Roche). Digested PAR was crushed and filtered on 100 μm cell strainers. Red blood cells were lysed using erythrolysis buffer (10 mM NaHCO~3~, 155 mM NH~4~Cl, and 10 mM EDTA) for 10 min at 37°C. Cells were washed in PBS/EDTA and frozen in FCS + 10% dimethyl sulfoxide (DMSO, Sigma-Aldrich, St Louis, MO).

*In vitro* infection
--------------------

For *in vitro* experiments, lungs from conventionally bred Large White sows were obtained from a commercial slaughterhouse. All tested samples were negative for PRRSV. Cells were collected and processed as for *in vivo* experiments (section Virus Production and Titration). Cell preparations were then enriched in mononuclear phagocyte cells by 1.065 density iodixanol gradient (Optiprep®, Nycomed Pharma, Oslo, Norway) as previously described ([@B25]). These gradient-enriched mononuclear phagocyte cell preparations will be further referred as gradient-enriched MPC. Infections (FL13, LV, and Lena) were performed on fresh enriched MPC, 24 h, in complete RPMI at MOI 0.5 suitable for the detection of cell infection using the anti-N intracellular staining and FACS analysis (see below). In order to avoid MPC adherence, incubations at 37°C were performed in Corning-Costar 50 ml polypropylene centrifuge tubes, with the cap drilled for air renewal. Two complementary negative controls were performed, inactivated Lena virus incubated at 37°C and live LV, FL13, and Lena viruses incubated with cells at 4°C for the whole 24 h culture time.

For purified DC subtypes (cDC1, cDC2, moDC) and Macrophages (AM and AM-like) infection, cells were sorted as described in cell-sorting section (section Cell Sorting and Flow Cytometry Analysis). Then, Lena infections were performed in complete RPMI for 24 h at a multiplicity of infection (MOI) of 0.001, suitable for the detection of cell infection using the highly sensitive RT-qPCR method (section RNA Extraction and RT-qPCR on Sorted Cells).

Cell sorting and flow cytometry analysis
----------------------------------------

Isolated BAL and PAR cells were stained in blocking solution, composed of PBS/EDTA supplemented with 5% Horse Serum and 5% Swine Serum. Antibodies were added to the blocking solution for 30 min on ice and then washed in PBS/EDTA with 2% FCS (for antibodies refer to Table [1](#T1){ref-type="table"}). Staining were made in 4 steps, the uncoupled primary antibodies of different species/isotypes (Chicken anti-CadM1, mouse IgG1 anti-CD172a, mouse IgG2a anti-CD1, mouse IgG2b anti-MHC-II) followed by the secondary species/isotype specific fluorochrome-coupled antibodies (anti-chicken-Alexa647, anti-mouse IgG1-Alexa488, anti-mouse IgG2a-PE-Cy7, anti-mouse IgG2b APC-Cy7), then the fluorochrome-coupled or biotinylated primary antibodies anti-CD163-PE, biotinylated anti-CD11c) followed by the streptavidin-coupled Alexa700 fluorochrome. DAPI staining (Sigma-Aldrich) was performed to exclude dead cells. Compensations were set according to monocolor staining. When needed, fluorescence minus one (FMO) controls, using isotype control for the unstained channel, were used to ascertain the specificity of the staining (CD169, N, CD80/86, CD40, MHC-I, MHC-II expressions). MoFlo ASTRIOS sorter (Beckman-Coulter, Paris, France) was used to isolate specific cell subpopulations. FlowJo software (version 10.1.0, Tree Star, Ashland, OR) was used to analyze subpopulation prevalence. Population prevalence is expressed as percentage of MHC-II^high^/CD11c^pos^ cells. Cells were analyzed using an LSRFortessa cytometer and Diva software (Becton Dickinson, Franklin Lakes, New Jersey).

###### 

Antibodies used for MPC cell sorting and infection analysis by flow cytometry.

  **Antibody**   **Clone**   **Isotype**   **Specie**   **Working oncentrations**       **Supplier**
  -------------- ----------- ------------- ------------ ------------------------------- -------------------------
  CadM1          3E1         IgY           Chicken      4 μg/ml                         MBL
  CD11c          3A8         IgG1          Mouse        2 μg/ml                         Homemade
  CD11c-biot     3A8         IgG1          Mouse        2 μg/ml                         Homemade
  CD163-PE       2A10/11     IgG1          Mouse        5 μg/ml                         Biorad
  CD169          1F1         IgG2a         Mouse        Pure (hybrifdoma supernatant)   Dr. J. Dominguez (INIA)
  CD172a/Sirpα   74-22-15    IgG1          Mouse        4 μg/ml                         WSU
                 74-22-15a   IgG2b         Mouse        4 μg/ml                         WSU
  CD1            76-7-4      IgG2a         Mouse        8 μg/ml                         WSU
  CD1-FITC       76-7-4      IgG2a         Mouse        4 μg/ml                         Southern Biotech
  MHCII          MSA3        IgG2a         Mouse        4 μg/ml                         WSU
  MHCII          Th21A       IgG2b         Mouse        4 μg/ml                         WSU
  N              BIO276      IgG1          Mouse        Diluted 1/30                    Bio-X Diagnostic

For intracellular virus detection, cells were stained using the same strategy as for cell-sorting. An additional intracellular staining step was performed using BD Cytofix/Cytoperm™ (Becton-Dickinson, Belgium), according to the manufacturer\'s instructions using an antibody against viral N protein (mouse IgG1, clone BIO 276, Bio-X Diagnostic) and a secondary anti-IgG1-PerCP-e710. In this case anti-MHC-II MSA3 (mouse IgG2a) and anti-CD172a 74-22-15a (mouse IgG2b) primary antibodies instead of Th21A and 74-22-15 respectively, as well as directly coupled CD1-FITC were used.

RNA extraction and RT-qPCR on sorted cells
------------------------------------------

Total RNA from sorted cells was extracted using the Arcturus PicoPure RNA Isolation kit (ThermoFisher Scientific, St Aubin, France) according to the manufacturer\'s instructions. The RNase-Free DNase Set (Qiagen, France) was used to remove contaminating DNA. Reverse transcription was made using Multiscribe reverse transcriptase (ThermoFisher Scientific) according to manufacturer\'s instructions. Relative mRNA expression was evaluated by qPCR using the iTaq Universal SYBR Green Supermix (Biorad, Hercules, CA). Relative gene expression was assessed according to ΔCt method. *Ribosomal protein S24* (*RPS24*) and *Glyceraldehyde 3-phosphate dehydrogenase* (*GAPDH)* were used as reference genes as previously described in pig lung ([@B21], [@B26]). For viral transcripts, primers were designed on the Lena protein N nucleocapsid sequence. In all *in vivo* and *in vitro* infection, data were normalized on *RPS24* and *GAPDH* reference genes, previously tested for stable expression among MPC subsets and upon PRRSV infection (data not shown). Since normalization with *RPS24* or *GAPDH* gave similar results, only *RPS24* normalization is depicted in the Figures **4**--**6** and **Data Sheet [1](#SM1){ref-type="supplementary-material"}**. Primers used are described in Table [2](#T2){ref-type="table"}. Titration of viral particles using RT-qPCR detection, set a limit of detection \< 1,000 particles/reaction (Ct \< 35).

###### 

Primers used for RT-qPCR.

  **Gene**    **Sequences (5′-3′)**          **Gene ID**   **Size (bp)**   **Eff**   **R^2^**   **Slope**
  ----------- ------------------------------ ------------- --------------- --------- ---------- -----------
  *FcεRIα*    F: CAGGTGTCCTTGAATCCCCC        100152827     74              1.07      0.998      −3.06
              R: GGCATCTGTATTTGCCGCTG                                                           
  *FOXP3*     F: GGTGCAGTCTCTCTGGAACAA       444998        148             1.10      0.982      −3.10
              R: GGTGCCAGTGGCTACAATAC                                                           
  *GATA3*     F: GTCTAGCAAATCCAAAAAGTGCAA    733631        75              1         0.999      −3.32
              R: GGGTTGAACGAGCTGCTCTT                                                           
  *GAPDH*     F: CACCATCTTCCAGGAGCGAG        396823        51              1         0.998      −3.32
              R: CCAGCATCACCCCACTTGAT                                                           
  *IFNα*      F: TCTGCAAGGTTCCCAATGG         397686        69              0.93      0.999      −3.50
              R: GGCATTGCAGCTGAGTAGCA                                                           
  *IFNβ*      F: TGTGGAACTTGATGGGCAGA        445459        92              0.98      0.993      −3.22
              R: GAATGGTCATGTCTCCCCTGG                                                          
  *IFNγ*      F: TGGTAGCTCTGGGAAACTGAATG     396991        79              1.01      0.972      −3.30
              R: TGGCTTTGCGCTGGATCT                                                             
  *IL4*       F: GCCGGGCCTCGACTGT            397225        68              1.06      0.999      −3.18
              R: TCCGCTCAGGAGGCTCTTC                                                            
  *IL6*       F: CTGCTTCTGGTGATGGCTACTG      399500        69              0.94      0.983      −3.49
              R: GGCATCACCTTTGGCATCTT                                                           
  *Il8*       F: TCCTGCTTTCTGCAGCTCTCT       396880        71              0.72      0.991      −3.30
              R: GCACTGGCATCGAAGTTCTG                                                           
  *IL10*      F: GAGCCAACTGCAGCTTCCA         397106        65              1.01      0.991      −3.29
              R: TCAGGACAAATAGCCCACTAGCTT                                                       
  *IL12p35*   F: CGTGCCTCGGGCAATTATAA        397053        66              0.99      0.998      −3.34
              R: CAGGTGAGGTCGCTAGTTTGG                                                          
  *IL12p40*   F: GGAGCACCCCACATTCCTACT       397076        68              0.98      0.973      −3.36
              R: TTCTCTTTTGTTCTTGCCCTGAA                                                        
  *IL13*      F:CTGACCACCAGCATGCAGTACT       396721        59              0.93      0.979      −3.50
              R: CGCTGGCAGTCGGAGATGTT                                                           
  *IL17*      F: CCAGACGGCCCTCAGATTAC        449530        65              0.98      0.999      −3.72
              R: GGTCCTCGTTGCGTTGGA                                                             
  *IL21*      F: AAATAGTCATCTGCCTGATGGTCAT   403123        76              1         0.989      −3.30
              R: AGGCGATCTTGTCCTTGGAA                                                           
  *MerTK*     F: CCGAACTCTGTAATCGCTTCTTG     100519652     65              0.74      0.990      −3.16
              R: TGCACTTCCGCCGTGACTA                                                            
  *N* Lena    F: ATGGCCAGCCAGTCAATCAG        1494888       166             0.95      0.993      −3.46
              R: GGAACGTTCAGTTCCGGTGA                                                           
  *RORγt*     F: CCTGGCCCTGGGCATGT           100622477     138             1.09      0.908      −3.117
              R: TGTTCTAGCAGCGTCCGAAGT                                                          
  *RPS24*     F: AAGGAACGCAAGAACAGAATGAA     100155012     62              0.98      1          −3.37
  ref. gene   R: TTTGCCAGCACCAACGTTG                                                            
  *T--bet*    F: TGCAGTCCCTCCATAAGTACCA      100518804     67              0.81      0.958      −3.32
              R: GCCTCTGGCTCACCATCATT                                                           
  *TGFβ*      F: GAAGCGCATCGAGGCCATTC        397078        162             0.85      0.999      −3.41
              R: GGCTCCGGTTCGACACTTTC                                                           
  *TNFα*      F: TGGTGGTGCCGACAGATG          397086        64              0.96      0.999      −3.42
              R: CAGCCTTGGCCCCTGAA                                                              
  *XCR1*      F: CGATGCCGTCTTCCACAAG         414375        61              1.01      0.989      −3.28
              R: GGAACCACTGGCGTTCTGA                                                            

Maturation markers surface expression
-------------------------------------

Expression of CD80/CD86, CD40, MHC-I, and MHC-II on DCs were studied by flow cytometry. Gradient-enriched MPC were cultured for 24 or 48 h with PRRSV (FL13, LV, and Lena) at MOI 0.5. For CD80/CD86 staining, the protein expressed by the human recombinant CD152 gene genetically fused with the Fc portion of the murine IgG2a sequence was used (Ancell, Bayport, MN, USA) (see Table [3](#T3){ref-type="table"}).

###### 

Antibodies used for maturation markers expressions and allogeneic lymphocytes proliferation assays.

  -------------------------------------------------------------------------------------------
  **Antibody**          **Clone**   **Isotype**   **Specie**   **Dilution**\   **Supplier**
                                                               **(μg/ml)**     
  --------------------- ----------- ------------- ------------ --------------- --------------
  CD152-muIg (CTLA-4)               IgG2a         Mouse        10              Ancell

  CD40                  G28.5       IgG1          Mouse        10              Genetex

  MHC-I                 JM1E3       IgG1          Mouse        10              BioRad

  CD3                   8E6         IgG1          Mouse        10              WSU

  CD4                   74-12-4     IgG2b         Mouse        10              WSU
  -------------------------------------------------------------------------------------------

Mixed lymphocytes reaction assay
--------------------------------

Mixed Lymphocytes Reaction (MLR) assays were performed as previously described ([@B27]). Briefly, fresh peripheral blood mononuclear cells (PBMC) from Melanoma Libechov Mini pigs were isolated on Ficoll-Paque density gradient (Amersham Biosciences, Uppsala, Sweden). Fresh parenchymal gradient-enriched MPC were cultured at 1.10^6^ cells/ml for 24 h with PRRSV (FL13, LV and Lena) at MOI 0.5 in complete RPMI. Following tests at different MPC:PBMC ratio (from 1:2 to 1:12), the 1:6 ratio has been selected for fresh MPC:PBMC final co-culture, with final total cell concentration of 2 × 10^6^ per ml in complete RPMI. After 3 days of co-culture, total RNA was extracted and gene expression were analyzed by RT-qPCR. Four transcriptions factors (*T-bet, GATA3, ROR*γ*T*, and *FOXP3*) and cytokines (*IFN*γ, *IL13, IL17*, and *TGF*β) expression were chosen as indicators of T-helper polarization (respectively Th1, Th2, Th17, and Treg). *IL13* has been chosen instead of *IL4* because *IL13* has been reported as a better porcine Th2 marker than *IL4*([@B28]). Data were normalized as described above in the RT-qPCR section. The same PBMC were CFSE stained and co-cultured with allogeneic infected gradient-enriched MPC in order to evaluate their proliferation rate. After 5 days of culture cells were stained using anti-CD3 and CD4 antibodies (Table [3](#T3){ref-type="table"}) and their corresponding isotype-specific secondary antibodies and analyzed on LSR Fortessa flow cytometer.

Cytokine bead assay
-------------------

In order to measure production of cytokines by MPC in response to infection, gradient-enriched MPC were infected with PRRSV (FL13, LV and Lena) for 24 h at MOI 0.5 in complete RPMI and supernatants were collected. Cytokine production was measured by Cytokine Bead Assay (CBA) as previously described ([@B21]), using capture and detection antibodies combinations described in Table [4](#T4){ref-type="table"}.

###### 

Antibodies used for CBA.

  **Cytokine**   **Capture antibodies**   **Detection antibodies (biotinylated)**                      
  -------------- ------------------------ ----------------------------------------- ------------------ -------------------
  IL-1β          77724                    R&DSystems                                pAb (\#BAF681)     R&DSystems
  IL-2           A150D3F1                 Invitrogen                                A150D8H10          Invitrogen
  IL-4           A155B16F2                Invitrogen                                A155B15C6          Invitrogen
  IL-6           pAb (\#AF686)            R&DSystems                                pAb (\#BAF686)     R&DSystems
  IL-8           105105                   R&DSystems                                pAb (\#BAF535)     R&DSystems
  IL-10          148801                   R&DSystems                                945A1A926C2        Invitrogen
  IL-12          G9                       KingfisherBiotech                         116211             R&DSystems
  IL-13          pAb (\#PB0094S)          KingfisherBiotech                         pAb (\#PBB0096S)   KingfisherBiotech
  IL-17          pAb (\#KP0498S)          KingfisherBiotech                         pAb (\#KPB0499S)   KingfisherBiotech
  TNFα           103104                   R&DSystems                                103302             R&DSystems
  IFNα           F17                      R&DSystems                                K9                 R&DSystems
  IFNγ           A151D5B8                 Invitrogen                                A151D13C5          Invitrogen

Statistical analysis
--------------------

All data were analyzed using R software (version 3.4.0) upgraded with FactoMineR package (version 1.39) ([@B29]). Non-parametric approaches were chosen due to the few number of samples available. The Mann-Whitney\'s test was used to compare unpaired samples based on ranking. For paired samples, the Wilcoxon matched-pairs signed rank test was used. Statistical tests and *p*-values are indicated in the relevant figure legends. MPC cytokine profile after *in vivo* infection of pigs were analyzed using Principal Component Analysis method (PCA). PCA multivariate analysis is a dimension-reduction tool that permit to reduce a large set of variables to a smaller one which still contains most of the information. A first PCA analysis was performed on BAL and PAR subpopulations in order to validate subpopulation clusters. Regarding quality and quantity of RNA, only 3 out of 4 cell-sorting samples were included for cytokine expression analysis. A second PCA analysis was performed on cytokines expressions from the 3 DCs populations and the 2 tissues (PAR and BAL) separately.

Results {#s3}
=======

Dendritic cells are not infected *in vivo* and *in vitro* by LENA
-----------------------------------------------------------------

Thanks to our previous work defining the phenotype and functions of the pig lung DC populations (cDC1, cDC2, and moDC) ([@B21]) we were able to refine our gating strategy in order to define each population by 4--5 different criterions, thus rendering our gating less sensitive to inflammation-induced markers modifications (Figure [1A](#F1){ref-type="fig"}). We used our newly described anti-CD11c antibody to gate myeloid cells ([@B30]). Conventional DC1 previously defined as MHC-II^high^/CD163^neg^/CD172a^neg/low^ will be defined here as MHC-II^high^/CD163^neg^/CD172a^neg/low^/CD11c^pos^/CadM1^pos^ (Figure [1A](#F1){ref-type="fig"}). Conventional DC2 previously defined as MHC-II^high^/CD163^neg^/CD172a^pos^ will be defined here as MHC-II^high^/CD163^neg^/CadM1^pos^/CD1^pos^ (Figure [1A](#F1){ref-type="fig"}) to comply with cDC2 definition in other tissues ([@B27], [@B31]). Conventional DC1 and cDC2 were negative for the two known PRRSV receptors CD163 and CD169 (Figure [1B](#F1){ref-type="fig"}), at steady state and upon infection. Monocyte derived-DC previously defined as MHC-II^high^/CD163^low^/CD172a^pos^ will be defined here as MHC-II^high^/CD163^low^/CD172a^pos^/CD11c^high^ (Figure [1A](#F1){ref-type="fig"}). CD163^high^/CD11c^high^ macrophages from BAL and parenchyma (PAR), called AM ([@B21]) and AM-like/PIM ([@B21], [@B32]) respectively were collected and used as positive control of infection in the following experiments. Monocyte-derived DC, AM-like/PIM and AM expressed CD169 and CD163 (Figure [1B](#F1){ref-type="fig"}), although moDC expressed lower level of CD163 as previously observed. AM ([@B33]) and PIM/AM-like ([@B32]) have been described to be the main PRRSV target cells, but they are unable to activate naïve T helper cells ([@B21]). This gating strategy was validated by cell-sorting of lung MPC upon mock and PRRSV infection and RT-qPCR of population specific genes (Supplementary Figure [S1A](#SM1){ref-type="supplementary-material"}). In both mock and infected animals, cDC1 exclusively presented a strong *XCR1* expression, whereas cDC2 presented a high *Fc*ε*RI*α expression, thus validating the cDC1 and cDC2 gating. We couldn\'t validate the moDCs sorting since no specific moDCs marker has been reported so far, neither in mouse ([@B34]--[@B36]) nor in human ([@B37], [@B38]) and swine ([@B14], [@B21]). As expected, *MerTK* was present in AM-like/PIM and AM. Surprisingly, in mock infected animals, steady state moDCs did not express *MertK*, whereas in our precedent experiments we observed variable *MertK* expression in moDC ([@B21], [@B26]). The discrepancy might originate from the use, here, of animals reared in highly controlled environment, whereas our previous studies were conducted using conventional animals. Indeed, upon Lena infection, we observed MertK upregulation in moDC (Supplementary Figure [S1A](#SM1){ref-type="supplementary-material"}), in concordance with a MertK upregulation in moDC in infectious conditions, although this hypothesis would need further validations. Since PRRSV is known to be cytolytic for infected cells, the evolution of each MPC population upon *in vivo* Lena infection was measured. Since the absolute number of MHC-II^high^/CD11c^pos^ MPC did not vary significantly among samples (PAR: 44.5.10^6^ ± 5.2.10^6^ cells in control animals vs. 40.8.10^6^ ± 4.6.10^6^ cells in infected animals; BAL: 44.1.10^6^ ± 9.2.10^6^ cells in control animals vs. 41.0.10^6^ ± 4.4.10^6^ cells in infected animals), the percentage of each MPC subtypes among MHC-II^high^/CD11c^pos^ cells was compared. Conventional DC1 and cDC2 proportions were not modified, whereas moDCs showed a trend to increase in parenchymal tissue (Figure [2A](#F2){ref-type="fig"}), and increased significantly in the alveolar lavages (Supplementary Figure [S1B](#SM1){ref-type="supplementary-material"}), in agreement with the pro-inflammatory infectious context. As previously observed ([@B32]), AM-like and AM proportions were strongly decreased (Figure [1A](#F1){ref-type="fig"}). The same cell populations were then sorted and viral RNAs were detected using RT-qPCR. The clear decrease of AM and AM-like proportions was concomitant with the detection of viral RNA. No significant viral RNA was observed in the 3 parenchymal DCs populations (Figure [2B](#F2){ref-type="fig"}) as well as in their alveolar counterparts (Supplementary Figure [S1C](#SM1){ref-type="supplementary-material"}).

![Mononuclear phagocytes (MPC) cell-sorting strategy. **(A)** Type 1 and Type 2 conventional dendritic cells (cDC1 and cDC2 respectively), monocyte-derived DCs (moDCs) and alveolar macrophages-like cells (AM-like) were isolated in infected or mock-infected lung parenchyma (PAR). MPC were defined by using MHC-II/CD11c/CD172a/CadM1/CD1 and CD163 markers. Identical process was performed on broncho-alveolar lavage (BAL) to collect alveolar macrophages (AM). Each graph is the offspring of the previous gate from left to right. Gates are numbered as G0 to G3. Data are representative of 4 independent cell-sorting experiments. **(B)** CD169 expression in MNP (Open black histogram) compared to isotype control (Closed gray histogram) and CD163 expression in MNP. Since CD163 is used in the gating of the different MNP populations, isotype control cannot be included.](fimmu-09-02299-g0001){#F1}

![DCs are not infected by Lena *in vivo*. **(A)**. Percentage of MPC were monitored in mock (Gray circle, 4 animals) and infected (Blue circle, 4 animals) BAL and lung parenchyma (PAR) after immunostaining. Data are expressed as a percentage of MHC-II^high^/CD11c^pos^ cells (see Gate1 in Figure [1A](#F1){ref-type="fig"}). The Mann-Whitney\'s test was performed. ^\*^*p* \< 0.05. **(B)** Detection of viral transcripts on sorted MPC was assessed by RT-qPCR. Primers designed on viral Nucleocapsid protein (N) were used to detect viral transcripts. Arbitrary unit: A.U. represents 2^−ΔCt^. The Mann-Whitney\'s test was performed. ^\*^*p* \< 0.05. **(C,D)** MPC from conventional pigs were isolated by cell sorting and infected *in vitro* for 24 h with Lena at multiplicity of infection (MOI) 10^−3^. AM and AM-like cultivated with inactivated virus were defined as PAR and BAL controls (PAR Ctrl and BAL Ctrl) respectively. **(C)** Intracellular viral transcripts were detected by RT-qPCR. **(D)** Production of infectious virions were detected by titration of supernatants on fresh AM, according to TCID50/ml method. Data are representative of 5 independent experiments. Wilcoxon matched-pairs signed rank test was performed. ^\*^*p* \< 0.05.](fimmu-09-02299-g0002){#F2}

To comfort this *in vivo* results, we cell-sorted the MPC of uninfected animals, and infected the cell populations *in vitro* at low MOI. AM and AM-like cultured with inactivated Lena were used as negative control for BAL and PAR respectively. After 2 days of culture, viral transcripts in the cell pellet as well as infectious virions in the culture supernatant were titrated by RT-qPCR and TCID50 methods respectively. Whereas AM-like and AM gave clear positive signals, no significant differences were observed between DCs and the negative controls with both detection methods (Figures [2C,D](#F2){ref-type="fig"}). This set of data clearly demonstrated, both *in vivo* and *in vitro*, that none of the 3 subsets of DCs were infected by Lena.

DCs are not infected *in vitro* by FL13 and LV
----------------------------------------------

Lena tropism was compared with that of FL13 and LV. An original *in vitro* model of infection using gradient enriched MPC was established. This method allows to keep the lung MPC complexity in an easy to handle cell suspension culture. After 24 h (an incubation time at which the cytopathic effect of PRRSV infection is not yet observed), viral infection was detected using an intracellular staining of viral N protein associated with the previously used MPC staining and gating (Figure [1](#F1){ref-type="fig"}). This model was validated by performing Lena infection and asserting the correlation between the levels of viral RNA by RT-qPCR (Figure [2](#F2){ref-type="fig"}) and N intracellular staining (data not shown). Controls with inactivated virus and 4°C incubated virus were performed (Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). For all strains, AM and AM-like presented N protein expression (Figure [3](#F3){ref-type="fig"}), validating the replication previously observed by RT-qPCR. In line with the previous *in vivo* and *in vitro* data, the viral protein was not detected in cDCs neither in PAR (Figure [3](#F3){ref-type="fig"}) nor in BAL (data not shown) for the 3 strains, in agreement with their lack of CD163 expression. In contrast with our *in vivo* and *in vitro*, cell sorted infection data (Figures [2A,B](#F2){ref-type="fig"}); using MPC mixed *in vitro* culture, a small but significant proportion (under 5%) of moDCs were N positive upon Lena, but not LV and FL13 infections (Figure [3](#F3){ref-type="fig"} and Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}).

![DCs are not infected by Lelystad and Flanders13 *in vitro*. MPC enriched parenchymal cells were infected for 16 h at MOI 0.5 with Flanders13 (FL13, Green triangle), Lelystad (LV, Red triangle), and Lena (Blue circle) strains. Mock-infected MPC were used as control (Ctrl). The cells were stained and gated as in Figure [1](#F1){ref-type="fig"}, except the additional step of an intracellular viral N protein staining. Data are representative of 6 independent experiments. Wilcoxon matched-pairs signed rank test was performed. ^\*^*p* \< 0.05.](fimmu-09-02299-g0003){#F3}

Lena but not FL13 and LV triggers a Th1 response *in vitro*
-----------------------------------------------------------

The resistance of DCs to PRRSV infection did not rule out a functional impairment of DCs by PRRSV, either through an early abortive infection or by an indirect bystander action. In order to test DCs functionalities upon PRRSV-1.1 and 1.3 infections, we used our *in vitro* infectious system to probe the complex action of the 3 strains on the whole lung MPC.

Production of cytokines by parenchymal MPC after infection was evaluated by CBA. IL12 and at a lesser extend IFNγ releases were significantly increased upon Lena but not LV and FL13 infections (Figure [4](#F4){ref-type="fig"}). No significant differences between viruses were observed for IL8, TNFα, IL4, IL6, IL13, and IL17. Maturation of DCs were tested *in vitro* by monitoring CD80/86, CD40, MHC-I, and MHC-II expressions by FACS analysis. No difference between strains appeared in these experiments (Supplementary Figure [S3A](#SM1){ref-type="supplementary-material"}).

![MPC exposure to Lena virus induces IL12A and IFNg secretions. MPC enriched PAR were cultured for 24 h at MOI 0.5 with FL13 (Green triangle), LV (Red triangle), and Lena (Blue circle) in complete RPMI. Supernatants were collected and analyzed by Cytokine Bead Assay (CBA). Data were normalized as fold change relative to control. The control samples mean has been calculated for each cytokine, then, each sample value, including the control sample values used for the reference mean calculation, is individually expressed as a percentage of this mean. Wilcoxon test was performed. ^\*^*p* \< 0.05.](fimmu-09-02299-g0004){#F4}

In order to analyze the ability of the pooled infected MPC to induce a T cell response, MLR assays were performed. MPC infected with any of the 3 strains induced a similar proliferation of CD4 T cells (Supplementary Figure [S3B](#SM1){ref-type="supplementary-material"}) in agreement with the absence of maturation markers expression differences. Using the same settings, we investigated more subtle functional differences by looking at the induction of T helper (Th) differentiation bias by measuring transcription factors and cytokines mRNA expressions after 3 days of allogeneic culture. Contrary to LV and FL13 infected MPC, Lena infected MPC showed a clear Th1 profile characterized by a higher expression of *T-bet* and *IFN*γ (Figure [5](#F5){ref-type="fig"}), in agreement with the detection of IL12 and IFNγ cytokines. Lena infection also triggered a significant *GATA-3* expression, paralleled with a non-significant *IL13* upregulation. Interestingly, in our settings no Treg nor Th17 induction was observed with any of the 3 strains.

![Lena infected MPC trigger a stronger Th1 response than LV and FL13. MPC-enriched PAR were cultured for 24 h with FL13 (Green triangle), LV (Red triangle), or Lena (Blue circle) at MOI 0.5 and then co-cultured with allogeneic PBMC at ratio 1:6. After 3 days of co-culture, RNA were extracted and gene expressions were analyzed by RT-qPCR. Four transcriptions factors (*T-bet, GATA3, ROR*γ*T*, and *FOXP3*) and cytokines (*IFN*γ, *IL13, IL17*, and *TGF*β) expressions were chosen as indicator of respectively Th1, Th2, Th17, and Treg polarization. Data were normalized to the reference gene *RPS24* expression and expressed as fold change relative to control. The control samples mean has been calculated for each cytokine, then, each control sample is expressed as a percentage of this mean. Wilcoxon test was performed. ^\*^*p* \< 0.05; ^\*\*^ \< 0.005.](fimmu-09-02299-g0005){#F5}

Lena infection *in vivo* activates the Th1-inducer cDC1
-------------------------------------------------------

Since DCs are the only activator of naïve T cells, and given the clear Th1 profile detected with Lena infection *in vitro*, we investigated DCs subpopulations\' activation *in vivo*. We assessed the cytokines mRNA expression levels of sorted DCs from 10 days mock and Lena infected animals. The expressions data were analyzed in a first PCA (Supplementary Figure [S4](#SM1){ref-type="supplementary-material"}). MPC subpopulations clearly segregated on the two first axis regardless of tissue (PAR vs. BAL) and infection status, thus clearly validating our sorting strategy.

Analysis of individual cytokines expression indicated trends of upregulation in cells from Lena infected animals for *IFN*α, *IL12p35, IL12p40, IL8*, and *TNF*α in cDC1, upregulation of *TGF*β in cDC2, and upregulation of *IL12p40* in moDCs. In AM-like *TGF*β was upregulated and *IL10* was down-regulated (Figure [6](#F6){ref-type="fig"}). These data were then analyzed globally in a second PCA analysis which showed a clear change in cDC1 cytokines profile under infectious conditions in PAR and BAL samples (Figure [7](#F7){ref-type="fig"}). For cDC2 and moDCs no clear differences were observed. It should be noticed that the same analysis in AM and AM-like gave no clear separation between cells from mock or infected animals (data not shown).

![Lena infection triggers differential cytokines responses according to DCs subpopulations. Cytokines mRNA expressions in MPC from mock (Gray Dots) or *in vivo* infected (Blue Dots) PAR and BAL were studied by RT-qPCR after cell-sorting. Data were normalized to the reference gene *RPS24* expression. Data are representative of 3 independent experiments. Ranking tests were performed. Symbol "\#" highlights when the infected animals were all upper or lower than the controls.](fimmu-09-02299-g0006){#F6}

![cDC1 are activated upon *in vivo* Lena infection. Principal Component Analysis (PCA) of DCs cytokines profile from PAR and BAL. The parameter values are cytokine mRNA expressions of sorted DCs from *in vivo* infected animals (Figure [6](#F6){ref-type="fig"}). Each pig is represented as a dot of specific color according to its group Mock (blue) or Lena (red). The percentages indicated on the axis represents the variance between individuals explain by this axis. The PCA was done with 10 factors (each of one represent a cytokine). PCA graphics has been produced using FactoMineR R package (version 1.39) ([@B29]). The ellipses depict the spread of the PCA data for mock or Lena infected conditions (blue and red respectively). Non-overlapping ellipses attest a significant difference in the global cytokine profile between mock and infected samples.](fimmu-09-02299-g0007){#F7}

Discussion {#s4}
==========

Here, *in vitro* and *in vivo* experiments were developed to study the interactions of lung DCs with different PRRSV-1. Our results demonstrate that the two types of cDCs (cDC1 and cDC2) are not infected by PRRSV-1. Using the MPC mix culture model, moDCs appeared susceptible, although weakly, to Lena, but not to PRRSV-1.1 infections whereas *in vivo* infected and freshly purified moDCs were not. One possible explanation is that monocytes present in lung MPC became sensitive to Lena infection upon culture as previously described for PRRSV2 ([@B39]) and then differentiated in moDCs in the course of *in vitro* culture in inflammatory conditions. This would explain contradictory results reported according to Lena infections experiments using MPC *ex vivo* or *in vitro* ([@B14], [@B15], [@B40]) as they might greatly depend upon the *in vitro* culture conditions. Although we were unable to identify and isolate lung plasmacytoid DCs (pDCs), a previous report on blood pDCs demonstrated that pDCs were also resistant to PRRSV infections ([@B41]). Thus, according to our *in vivo* and *in vitro* data, we can confidently state that none of the known DCs subtypes of the porcine lung can be consistently infected by PRRSV-1.

The resistance to PRRSV infection of *in vivo* differentiated cDCs appears in line with the absence of expression in these cells of the two main PRRSV receptors CD169 and CD163 (Figure [1](#F1){ref-type="fig"}) ([@B21]). To note, Siglec-10 has been recently described as a possible alternative to CD169 (Siglec-1) receptor ([@B42]). However Siglec-10 expression seems restricted to B cells ([@B43]), and would not compensate for the absence of CD163 expression on cDCs, CD163 being so far the only receptor whose deletion totally abrogates *in vivo* PRRSV replication ([@B44], [@B45]). Conversely, *in vivo* differentiated moDCs expressed CD169 and low levels of CD163 \[Figure [1](#F1){ref-type="fig"}; ([@B21])\] that might be upregulated upon *in vitro* culture, which would explain the infection of moDCs depending on culture conditions and PRRSV type.

In Lena infected animals, the absence of DCs infection did not preclude the cDC1 activation and the development of an antiviral Th1 immune response. This is in agreement with the role of cDC1 in the antiviral Th1/T CD8 inducing response, as previously observed in porcine ([@B21]) and murine (CD103^pos^ DCs) ([@B46], [@B47]) respiratory tracts. Lung mouse cDC1 (CD103^+^) have been shown to be resistant to Influenza virus infection while cross-presenting efficiently viral antigens to T cells ([@B48]). Moreover it has been recently demonstrated that human cDC1 were resistant to infection by endocytic enveloped viruses such as HIV and Influenza but relied on viral antigens produced by bystander cells that they can cross-present to trigger T cell responses ([@B49]). In the case of PRRSV, those antigens might come from apoptotic infected macrophages. Indeed cDC1 from murine lung (CD103^pos^ DCs) ([@B50]) and from pig skin (CD172a^neg/low^ dermal DCs)([@B25]) preferentially phagocytosed apoptotic bodies. Activation of porcine cDC1 can be triggered through TLR8 ([@B31]) which is activated by single-strand RNA viruses ([@B51]) or through the accumulation of late apoptotic/secondary necrotic, pro-inflammatory AM that might accumulate in the lung \[for review see ([@B52])\]. This bystander activation of cDC1 can be compared to the previously described *in vitro* activation of pDCs ([@B53]) by PRRSV-infected macrophages. We can thus speculate that Lena-infected apoptotic AM are taken over by cDC1 that get activated by virus-laden apoptotic bodies. Conventional cDC1 then activate the Th1/TCD8 immune responses. We have to stress here that our data used allogeneic induced responses, but did not formally demonstrate PRRSV-specific antigen presentations. However, interestingly, the Th1 immune response induced by PRRSV-1.3 has been correlated with the clinical score ([@B5]) suggesting that the antigen-specific anti-PRRSV Th1 response would be involved in the higher pathogenicity of PRRSV-1.3 strains. Whereas this Lena-triggered cDC1 activation appears finally quite classical, we would like to stress that the converse lack of cDC1/Th1 activation with PRRSV-1.1 viruses might indeed deserve more attention.
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AM

:   Alveolar Macrophages

AM-like

:   Alveolar Macrophages like

BAL

:   Broncho-Alveolar Lavage

cDC1

:   conventional Dendritic Cells type 1

cDC2

:   conventional Dendritic Cells type 2

CBA

:   Cytokine Bead Assay

DCs

:   Dendritic Cells

FL13

:   Flanders13 virus

LV

:   Lelystad virus

moDC

:   Monocyte-derived Dendritic Cells

MPC

:   Mononuclear Phagocyte Cells

MP

:   Multiplicity Of Infection

PAR

:   Parenchyma

pDCs

:   plasmacytoid Dendritic Cells

PRRSV

:   Porcine Reproductive and Respiratory Syndrome Virus

PCA

:   Principal Component Analysis.
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